Can we identify patients with low grade lymphoma for frontline ABMT?

@article{Romaguera1993CanWI,
  title={Can we identify patients with low grade lymphoma for frontline ABMT?},
  author={Jorge E Romaguera},
  journal={Leukemia & lymphoma},
  year={1993},
  volume={10 Suppl},
  pages={9-15}
}
Autologous Bone Marrow Transplant (ABMT), at this point, is an experimental procedure reserved for patients without cure potential with available conventional chemotherapy. Unfortunately, the Ann Arbor staging system has not been able to identify these cases since there are patients with Stage IV who do well and others who do not. We have reported on a risk model based on gender and tumor burden (TB) assessment that can stratify patients with uniform Ann Arbor stage IV follicular low-grade… CONTINUE READING